Logo image of AZZ.CA

AZARGA URANIUM CORP (AZZ.CA) Stock Fundamental Analysis

TSX:AZZ - Toronto Stock Exchange - Common Stock

0.71  +0.05 (+7.58%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to AZZ. AZZ was compared to 217 industry peers in the Oil, Gas & Consumable Fuels industry. AZZ has a bad profitability rating. Also its financial health evaluation is rather negative. AZZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AZZ had negative earnings in the past year.
AZZ.CA Yearly Net Income VS EBIT VS OCF VS FCFAZZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 -2M -4M -6M

1.2 Ratios

Industry RankSector Rank
ROA -17.9%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AZZ.CA Yearly ROA, ROE, ROICAZZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AZZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AZZ.CA Yearly Profit, Operating, Gross MarginsAZZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for AZZ has been increased compared to 1 year ago.
The debt/assets ratio for AZZ is higher compared to a year ago.
AZZ.CA Yearly Shares OutstandingAZZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 50M 100M 150M 200M
AZZ.CA Yearly Total Debt VS Total AssetsAZZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 10M 20M 30M 40M

2.2 Solvency

AZZ has an Altman-Z score of 7.96. This indicates that AZZ is financially healthy and has little risk of bankruptcy at the moment.
AZZ has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.96
ROIC/WACCN/A
WACCN/A
AZZ.CA Yearly LT Debt VS Equity VS FCFAZZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 7.68 indicates that AZZ has no problem at all paying its short term obligations.
A Quick Ratio of 7.68 indicates that AZZ has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 7.68
Quick Ratio 7.68
AZZ.CA Yearly Current Assets VS Current LiabilitesAZZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

AZZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -424.20%.
EPS 1Y (TTM)-424.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1114.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AZZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.16% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2Y-22.47%
EPS Next 3Y0%
EPS Next 5Y3.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AZZ.CA Yearly Revenue VS EstimatesAZZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 200K 400K 600K
AZZ.CA Yearly EPS VS EstimatesAZZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 2019 2020 2021 2022 2023 2024 2025 -0.01 -0.02 -0.03

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AZZ. In the last year negative earnings were reported.
Also next year AZZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZZ.CA Price Earnings VS Forward Price EarningsAZZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -75.96
AZZ.CA Per share dataAZZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-22.47%
EPS Next 3Y0%

More info and screens

0

5. Dividend

5.1 Amount

AZZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AZARGA URANIUM CORP

TSX:AZZ (1/5/2022, 7:00:00 PM)

0.71

+0.05 (+7.58%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners11.3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap180.42M
Analysts45.71
Price Target0.91 (28.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.85
P/tB N/A
EV/EBITDA -75.96
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.18
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.68
Quick Ratio 7.68
Altman-Z 7.96
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-424.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1114.84%
EPS Next Y0%
EPS Next 2Y-22.47%
EPS Next 3Y0%
EPS Next 5Y3.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A